US5780222A
(en)
|
1995-04-10 |
1998-07-14 |
Alpha Therapeutic Corporation |
Method of PCR testing of pooled blood samples
|
WO1998016201A1
(en)
*
|
1996-10-11 |
1998-04-23 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method
|
US20050025819A1
(en)
*
|
1997-07-14 |
2005-02-03 |
Hayat Onyuksel |
Materials and methods for making improved micelle compositions
|
US20020115609A1
(en)
*
|
1997-07-14 |
2002-08-22 |
Hayat Onyuksel |
Materials and methods for making improved micelle compositions
|
US6372720B1
(en)
|
1998-02-05 |
2002-04-16 |
Kenneth J. Longmuir |
Liposome fusion and delivery vehicle
|
NZ508950A
(en)
|
1998-07-13 |
2003-10-31 |
Univ Texas |
Cancer treatment methods using antibodies to aminophospholipids
|
US6818213B1
(en)
|
1998-07-13 |
2004-11-16 |
Board Of Regents, The University Of Texas System |
Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
|
WO2000002587A1
(en)
*
|
1998-07-13 |
2000-01-20 |
Board Of Regents, The University Of Texas System |
Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
|
US6406693B1
(en)
|
1998-07-13 |
2002-06-18 |
Board Of Regents, The University Of Texas System |
Cancer treatment methods using antibodies to aminophospholipids
|
US6379698B1
(en)
|
1999-04-06 |
2002-04-30 |
Isis Pharmaceuticals, Inc. |
Fusogenic lipids and vesicles
|
AU783647B2
(en)
*
|
1999-04-20 |
2005-11-17 |
University Of British Columbia, The |
Cationic peg-lipids and methods of use
|
US7238368B2
(en)
|
1999-04-23 |
2007-07-03 |
Alza Corporation |
Releasable linkage and compositions containing same
|
DE60030965T2
(de)
|
1999-04-23 |
2007-05-24 |
Alza Corp., Mountain View |
Konjugate enthaltend eine spaltbare bindung zur anwendung in einem liposom
|
US7112337B2
(en)
|
1999-04-23 |
2006-09-26 |
Alza Corporation |
Liposome composition for delivery of nucleic acid
|
US7303760B2
(en)
|
1999-04-23 |
2007-12-04 |
Alza Corporation |
Method for treating multi-drug resistant tumors
|
AUPQ014699A0
(en)
*
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using nanoparticles
|
WO2001041738A2
(en)
*
|
1999-12-10 |
2001-06-14 |
Celator Technologies Inc. |
Lipid carrier compositions with protected surface reactive functions
|
US20060177416A1
(en)
|
2003-10-14 |
2006-08-10 |
Medivas, Llc |
Polymer particle delivery compositions and methods of use
|
AU2002225878A1
(en)
*
|
2000-11-02 |
2002-05-15 |
Smith Kline Beecham Corporation |
Receptor antagonist-lipid conjugates and delivery vehicles containing same
|
WO2002057424A2
(en)
*
|
2001-01-17 |
2002-07-25 |
Zycos Inc. |
Nucleic acid delivery formulations
|
AU2002305094B2
(en)
*
|
2001-03-26 |
2007-01-11 |
Alza Corporation |
Liposome composition for improved intracellular delivery of a therapeutic agent
|
WO2002078672A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Alza Corporation |
Liposomal tumor necrosis factor compositions and methods
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
AU2002368202B2
(en)
|
2001-11-02 |
2008-06-05 |
Insert Therapeutics, Inc |
Methods and compositions for therapeutic use of RNA interference
|
US20040219201A1
(en)
*
|
2001-12-06 |
2004-11-04 |
Yechezkel Barenholz |
Tempamine compositions and methods of use
|
US20040147466A1
(en)
*
|
2002-01-17 |
2004-07-29 |
Barman Shikha P. |
Nucleic acid delivery formulations
|
DE10207178A1
(de)
*
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
CN100577203C
(zh)
|
2002-07-18 |
2010-01-06 |
赫利克斯生物药品公司 |
尿素酶用于抑制癌症细胞生长的用途
|
US20040161468A1
(en)
*
|
2002-12-04 |
2004-08-19 |
L'oreal |
Stabilization of aromatic active principles using aromatic polymers
|
FR2848101B1
(fr)
*
|
2002-12-04 |
2006-08-11 |
Oreal |
Procede de traitement cosmetique des matieres keratiniques impliquant la liberation controlee de principes actifs aromatiques a partir de particules de polymere aromatique
|
EP1587484A4
(en)
*
|
2002-12-19 |
2008-11-12 |
Alza Corp |
METHOD OF TREATING ANGIOGENIC TISSUE GROWTH
|
CN102775472A
(zh)
|
2003-01-06 |
2012-11-14 |
安吉奥开米公司 |
作为穿过血脑屏障的载体的抑酶肽及类似物
|
WO2004087097A2
(en)
*
|
2003-03-31 |
2004-10-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer
|
US11324698B2
(en)
|
2003-08-28 |
2022-05-10 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
|
US8846079B1
(en)
|
2004-12-01 |
2014-09-30 |
Vgsk Technologies, Inc. |
Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
|
US20060115523A1
(en)
*
|
2004-12-01 |
2006-06-01 |
Konduri Kameswari S |
Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal
|
IL158599A0
(en)
*
|
2003-10-26 |
2004-05-12 |
Yeda Res & Dev |
Methods of modulating hematopoiesis
|
EP1691780A2
(en)
*
|
2003-11-21 |
2006-08-23 |
Alza Corporation |
Gene delivery mediated by liposome-dna complex with cleavable peg surface modification
|
US7208174B2
(en)
*
|
2003-12-18 |
2007-04-24 |
Hoffmann-La Roche Inc. |
Liposome compositions
|
WO2005094880A1
(en)
*
|
2004-03-30 |
2005-10-13 |
Canadian Blood Services |
Method for treating autoimmune diseases with antibodies
|
CA2562527A1
(en)
*
|
2004-04-21 |
2005-11-10 |
Alza Corporation |
Polymer conjugate releasable under mild thiolytic conditions
|
US20050281740A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue
|
US7678767B2
(en)
|
2004-06-16 |
2010-03-16 |
Pneumrx, Inc. |
Glue compositions for lung volume reduction
|
US7608579B2
(en)
*
|
2004-06-16 |
2009-10-27 |
Pneumrx, Inc. |
Lung volume reduction using glue compositions
|
US7553810B2
(en)
*
|
2004-06-16 |
2009-06-30 |
Pneumrx, Inc. |
Lung volume reduction using glue composition
|
US7468350B2
(en)
|
2004-06-16 |
2008-12-23 |
Pneumrx, Inc. |
Glue composition for lung volume reduction
|
US20050281798A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Targeting sites of damaged lung tissue using composition
|
US20050281739A1
(en)
*
|
2004-06-16 |
2005-12-22 |
Glen Gong |
Imaging damaged lung tissue using compositions
|
WO2006014567A2
(en)
*
|
2004-07-08 |
2006-02-09 |
Pneumrx, Inc. |
Pleural effusion treatment device, method and material
|
JP2008512445A
(ja)
*
|
2004-09-09 |
2008-04-24 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム |
炎症状態の治療のためのリポソーム性グルココルチコイドの使用
|
EP1793805A1
(en)
*
|
2004-09-09 |
2007-06-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal formulations comprising an amphipathic weak base like tempamine for treatment of neurodegenerative conditions
|
US6998028B1
(en)
*
|
2004-09-24 |
2006-02-14 |
Superpower, Inc. |
Methods for forming superconducting conductors
|
TW200612993A
(en)
*
|
2004-10-08 |
2006-05-01 |
Alza Corp |
Lipopolymer conjugates
|
TW200618820A
(en)
*
|
2004-11-05 |
2006-06-16 |
Alza Corp |
Liposome formulations of boronic acid compounds
|
EP1817004A2
(en)
*
|
2004-11-15 |
2007-08-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combination therapy associating preferably a ceramide with a cytotoxic drug
|
PT2360258E
(pt)
*
|
2005-02-18 |
2015-01-13 |
Angiochem Inc |
Moléculas para transportar um composto através da barreira hematoencefálica
|
US20090016959A1
(en)
*
|
2005-02-18 |
2009-01-15 |
Richard Beliveau |
Delivery of antibodies to the central nervous system
|
US20070014845A1
(en)
*
|
2005-07-01 |
2007-01-18 |
Yuanpeng Zhang |
Liposomal delivery vehicle for hydrophobic drugs
|
PL2233156T3
(pl)
|
2005-07-15 |
2013-09-30 |
Angiochem Inc |
Zastosowanie polipeptydów aprotyninowych jako nośników w koniugatach farmaceutycznych
|
US20070055199A1
(en)
*
|
2005-08-10 |
2007-03-08 |
Gilbert Scott J |
Drug delivery device for buccal and aural applications and other areas of the body difficult to access
|
WO2007038246A2
(en)
|
2005-09-22 |
2007-04-05 |
Medivas, Llc |
Solid polymer delivery compositions and methods for use thereof
|
US8445007B2
(en)
|
2005-09-22 |
2013-05-21 |
Medivas, Llc |
Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use
|
EP1929073A4
(en)
*
|
2005-09-27 |
2010-03-10 |
Amunix Inc |
PROTEIN MEDICAMENT AND ITS USE
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
US20090155345A1
(en)
*
|
2005-12-08 |
2009-06-18 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for affecting liposome composition ultrasound irradiation
|
US7446096B2
(en)
*
|
2005-12-19 |
2008-11-04 |
Industrial Technology Research Institute |
Glutathione based delivery system
|
US8067380B2
(en)
|
2005-12-19 |
2011-11-29 |
Industrial Technology Research Institute |
Glutathione-based delivery system
|
EP2918283B1
(en)
*
|
2005-12-30 |
2018-01-31 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Extended release of neuregulin for improved cardiac function
|
US8597636B2
(en)
*
|
2006-01-13 |
2013-12-03 |
Canadian Blood Services |
Method for treating autoimmune diseases and compositions therefor
|
US20070218116A1
(en)
*
|
2006-03-14 |
2007-09-20 |
Schwendener Reto A |
Compositions and methods for the treatment of tumors and tumor metastases
|
DE102007004303A1
(de)
*
|
2006-08-04 |
2008-02-07 |
Osram Opto Semiconductors Gmbh |
Dünnfilm-Halbleiterbauelement und Bauelement-Verbund
|
US20090054317A1
(en)
*
|
2006-08-14 |
2009-02-26 |
Kane Ravindra S |
Polyvalent inhibitors of pathogens
|
EP2058009A4
(en)
*
|
2006-08-31 |
2009-10-28 |
Astellas Pharma Inc |
REVERSE TARGETING-lipid vesicles
|
US20100297218A1
(en)
*
|
2006-09-20 |
2010-11-25 |
Pneumrx, Inc. |
Tissue adhesive compositions and methods thereof
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
WO2009006311A2
(en)
*
|
2007-06-29 |
2009-01-08 |
Wisconsin Alumni Research Foundation |
Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals
|
EP2185701A4
(en)
*
|
2007-08-15 |
2011-03-02 |
Amunix Operating Inc |
COMPOSITIONS AND METHODS FOR ENHANCING THE PRODUCTION OF RECOMBINANT POLYPEPTIDES
|
CN101970012A
(zh)
*
|
2007-09-14 |
2011-02-09 |
日东电工株式会社 |
药物载体
|
CA2700378A1
(en)
*
|
2007-09-21 |
2009-03-29 |
Cytimmune Sciences, Inc. |
Nanotherapeutic colloidal metal compositions and methods
|
ES2916498T3
(es)
|
2007-12-06 |
2022-07-01 |
Genalyte Inc |
Método para identificar una secuencia de nucleótidos en una especie desconocida de ácido nucleico; y dispositivo para llevar a cabo el método
|
WO2009127072A1
(en)
*
|
2008-04-18 |
2009-10-22 |
Angiochem Inc. |
Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and related methods of preparation and use
|
US8231895B2
(en)
|
2008-05-22 |
2012-07-31 |
Universidade De Coimbra |
Targeted delivery to human diseases and disorders
|
US8239357B1
(en)
*
|
2008-09-12 |
2012-08-07 |
Ryan, LLC |
Method and system for extracting information from electronic data sources
|
US8828925B2
(en)
|
2008-10-15 |
2014-09-09 |
Angiochem Inc. |
Etoposide and doxorubicin conjugates for drug delivery
|
US8921314B2
(en)
|
2008-10-15 |
2014-12-30 |
Angiochem, Inc. |
Conjugates of GLP-1 agonists and uses thereof
|
ES2939310T3
(es)
|
2008-10-27 |
2023-04-20 |
Genalyte Inc |
Biosensores basados en sondeo y detección ópticos
|
US9914754B2
(en)
*
|
2008-12-05 |
2018-03-13 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
JP2012512185A
(ja)
|
2008-12-17 |
2012-05-31 |
アンジオケム インコーポレーテッド |
膜1型マトリックス金属タンパク質阻害剤およびその使用
|
CN102307570A
(zh)
*
|
2009-01-15 |
2012-01-04 |
德克萨斯州大学系统董事会 |
改变生物降解动力学性能的多孔结构
|
US20110046060A1
(en)
|
2009-08-24 |
2011-02-24 |
Amunix Operating, Inc., |
Coagulation factor IX compositions and methods of making and using same
|
CN116925238A
(zh)
*
|
2009-02-03 |
2023-10-24 |
阿穆尼克斯制药公司 |
延伸重组多肽和包含该延伸重组多肽的组合物
|
DE102009012640A1
(de)
*
|
2009-03-09 |
2010-09-30 |
Freie Universität Berlin |
Mit einer Phosphoamidatgruppe modifizierte Verbindung und deren Verwendung
|
ES2729261T3
(es)
|
2009-04-20 |
2019-10-31 |
Angiochem Inc |
Tratamiento del cáncer de ovario utilizando un agente anticancerígeno conjugado con un análogo de Angiopep-2
|
LT2440241T
(lt)
|
2009-06-08 |
2017-10-10 |
Amunix Operating Inc. |
Augimo hormonų polipeptidai ir jų gamybos bei panaudojimo būdai
|
CA2764108A1
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
WO2010143193A1
(en)
|
2009-06-11 |
2010-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Targeted liposomes comprising n-containing bisphosphonates and uses thereof
|
CN102596993A
(zh)
|
2009-07-02 |
2012-07-18 |
安吉奥开米公司 |
多聚体肽结合物以及其应用
|
BR112012009801A8
(pt)
|
2009-10-30 |
2016-08-30 |
Cns Therapeutics Inc |
Polipeptídeo neurturina e variante de neurturina
|
TWI397428B
(zh)
*
|
2009-12-29 |
2013-06-01 |
Ind Tech Res Inst |
標的第四介白素受體之傳輸系統
|
EP2531175A2
(en)
|
2010-02-01 |
2012-12-12 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Liposomes comprising amphipathic drugs and method for their preparation
|
CA2816995C
(en)
|
2010-11-05 |
2019-12-31 |
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, a body corporate and politic |
Optical analyte detection systems and methods of use
|
US9873765B2
(en)
|
2011-06-23 |
2018-01-23 |
Dsm Ip Assets, B.V. |
Biodegradable polyesteramide copolymers for drug delivery
|
JP6045575B2
(ja)
|
2011-06-23 |
2016-12-14 |
ディーエスエム アイピー アセッツ ビー.ブイ. |
薬物送達のための新規な生分解性ポリエステルアミドコポリマー
|
LT2731591T
(lt)
|
2011-07-13 |
2020-12-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Liposomos, kuriose kartu inkapsuliuotas bisfosfonatas ir amfipatinis agentas
|
WO2013114377A1
(en)
|
2012-02-02 |
2013-08-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd |
Stable liposomes for drug delivery
|
US10421798B2
(en)
|
2012-02-15 |
2019-09-24 |
Bioverativ Therapeutics Inc. |
Factor VIII compositions and methods of making and using same
|
SI2822577T1
(sl)
|
2012-02-15 |
2019-07-31 |
Bioverativ Therapeutics Inc. |
Rekombinantni proteini faktorja VIII
|
EP2825885B1
(en)
|
2012-03-12 |
2021-05-12 |
The Board of Trustees of the University of Illinois |
Optical analyte detection systems with magnetic enhancement
|
LT2859015T
(lt)
|
2012-06-08 |
2018-07-10 |
Alkermes Pharma Ireland Limited |
Ligandai, modifikuoti cikline permutacija, kaip agonistai ir antagonistai
|
CN102920658B
(zh)
*
|
2012-11-02 |
2015-01-21 |
艾韦特(溧阳)医药科技有限公司 |
与glp-1类似物和聚乙二醇结合的脂质体及其制备方法
|
TW202003554A
(zh)
|
2013-08-14 |
2020-01-16 |
美商百歐維拉提夫治療公司 |
因子viii-xten融合物及其用途
|
WO2015073587A2
(en)
|
2013-11-18 |
2015-05-21 |
Rubius Therapeutics, Inc. |
Synthetic membrane-receiver complexes
|
MX2016012168A
(es)
|
2014-03-25 |
2017-04-25 |
The Government Of The Us Secretary Of The Army |
Formulacion adyuvante no toxica que comprende una composicion de liposoma que contiene monofosforil-lipido a (mpla) y una saponina.
|
EP3125927B1
(en)
|
2014-04-01 |
2021-01-27 |
Rubius Therapeutics, Inc. |
Methods and compositions for immunomodulation
|
US10434071B2
(en)
|
2014-12-18 |
2019-10-08 |
Dsm Ip Assets, B.V. |
Drug delivery system for delivery of acid sensitivity drugs
|
WO2016116907A1
(en)
|
2015-01-23 |
2016-07-28 |
Helix Biopharma Corporation |
Antibody-urease conjugates for therapeutic purposes
|
JP6859275B2
(ja)
|
2015-03-17 |
2021-04-14 |
リポメディックス・ファーマシューティカルズ・リミテッドLipomedix Pharmaceuticals Ltd. |
膀胱がんの治療方法
|
CA2989400A1
(en)
|
2015-06-15 |
2016-12-22 |
Angiochem Inc. |
Ang1005 for the treatment of leptomeningeal carcinomatosis
|
US10745680B2
(en)
|
2015-08-03 |
2020-08-18 |
Bioverativ Therapeutics Inc. |
Factor IX fusion proteins and methods of making and using same
|
CN108778289B
(zh)
|
2015-11-06 |
2020-11-17 |
佐剂技术公司 |
三萜皂苷类似物
|
EP3595636A4
(en)
|
2017-03-16 |
2021-01-13 |
Children's Medical Center Corporation |
GENETICALLY PRODUCED LIPOSOMES AS TARGETED THERAPEUTICS AGAINST CANCER
|
AU2018350887A1
(en)
|
2017-10-16 |
2020-03-05 |
Adjuvance Technologies, Inc. |
Triterpene saponin analogues
|
JP2020026397A
(ja)
*
|
2018-08-09 |
2020-02-20 |
国立大学法人 岡山大学 |
TrkBアンタゴニストを含む医薬組成物
|
WO2023175454A1
(en)
|
2022-03-14 |
2023-09-21 |
Pfizer Inc. |
Methods for producing an adjuvant
|
WO2024116096A1
(en)
|
2022-12-01 |
2024-06-06 |
Pfizer Inc. |
Pneumococcal conjugate vaccine formulations
|